Sirona Biochem (FRA:ZSB) COGS-to-Revenue : 0.00 (As of Jan. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sirona Biochem COGS-to-Revenue?

Sirona Biochem's Cost of Goods Sold for the three months ended in Jan. 2024 was €0.00 Mil. Its Revenue for the three months ended in Jan. 2024 was €0.00 Mil.

Sirona Biochem's COGS to Revenue for the three months ended in Jan. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sirona Biochem's Gross Margin % for the three months ended in Jan. 2024 was N/A%.

Sirona Biochem COGS-to-Revenue Historical Data

The historical data trend for Sirona Biochem's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem COGS-to-Revenue Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

COGS-to-Revenue

Get a 7-Day Free Trial

Sirona Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Sirona Biochem COGS-to-Revenue Calculation

Sirona Biochem's COGS to Revenue for the fiscal year that ended in Oct. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.024
	=	0.00

Sirona Biochem's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.001
	=	0.00

Sirona Biochem (FRA:ZSB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sirona Biochem's Gross Margin % for the three months ended in Jan. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.001
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sirona Biochem COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sirona Biochem (FRA:ZSB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (FRA:ZSB) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

SRBCF:USA ZSB:Germany SBM:Canada

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (FRA:ZSB) Headlines

No Headlines